The global Wearable Artificial Kidney Market experienced robust growth in 2022, with a total valuation of USD 164 billion. Forecasts indicate that by 2032, it is poised to reach a staggering USD 201 billion, marking an impressive compound annual growth rate (CAGR) of 11.2% during this ten-year period. Several pivotal factors contribute to this upward trajectory in market revenue, including the escalating prevalence of Chronic Kidney Disease (CKD), a growing demand for at-home and portable dialysis solutions, ongoing advancements in artificial kidney technologies, and a surge in patients requiring kidney transplants.
Chronic Kidney Disease (CKD) is a global health crisis, with millions of individuals affected worldwide. According to estimates from the National Kidney Foundation, approximately 10% of the global population grapples with CKD, translating to millions of patients in dire need of kidney dialysis or transplantation. The Wearable Artificial Kidney (WAK) emerges as a cutting-edge dialysis therapy that has gained popularity among CKD patients. This innovative device grants patients the freedom to move about while undergoing dialysis, effectively replicating the natural kidney's functionality and conveniently worn as a belt or harness.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/7486
One of the primary drivers behind the remarkable revenue growth in the wearable artificial kidney market is the surging demand for portable and home-based dialysis services. Traditional dialysis treatments necessitate patients to spend hours in a hospital or dialysis facility, typically three times a week. However, the WAK device empowers patients to conduct dialysis at home or on the go, substantially reducing hospital visits and enhancing overall convenience. This development is particularly advantageous for older patients and individuals with limited mobility.
Technological advancements in artificial kidney devices also play a pivotal role in driving revenue growth within the wearable artificial kidney market. Companies continually invest in research and development to enhance the usability and mobility of WAK devices. Notably, in 2019, the FDA approved a clinical trial for a wearable artificial kidney developed by Blood Purification Technologies, Inc., designed to deliver continuous dialysis for up to 24 hours.
Market Segment Analysis:
The wearable artificial kidney market encompasses two primary product segments: Hemodialysis devices and Peritoneal Dialysis devices. In 2022, hemodialysis equipment dominated the market, accounting for the majority of revenue. Hemodialysis, a well-established treatment for renal failure, involves filtering a patient's blood through an external machine via a dialysis catheter inserted into an arm or leg vein. This procedure can be carried out at home with the assistance of a caregiver or in a hospital or dialysis facility. Hemodialysis equipment is designed to be portable and mobile, enabling patients to maintain their daily routines while receiving treatment.
In contrast, peritoneal dialysis equipment held a smaller share of the market revenue in 2021. Peritoneal dialysis filters blood through the peritoneal membrane in the abdominal region. Patients who cannot or prefer not to travel to a medical facility can conveniently undergo this procedure at home. However, peritoneal dialysis requires the use of an abdominal catheter, which some patients find uncomfortable. Maintaining a hygienic environment for peritoneal dialysis at home can also pose challenges.
Throughout the forecast period, hemodialysis devices are anticipated to maintain their market dominance. This is primarily due to the established efficacy of hemodialysis in treating renal failure and the portability and user-friendliness of hemodialysis equipment. Furthermore, the preference for home hemodialysis is growing as patients seek the comfort and convenience of receiving care at home.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/7486
End-Use Sector Analysis:
The wearable artificial kidney market serves various end-use sectors, including hospitals, clinics, and home care settings. In 2022, the hospital segment dominated in terms of revenue. This dominance can be attributed to the rise in hospital visits stemming from the prevalence of chronic diseases and an aging population. Hospitals require cutting-edge medical equipment to provide efficient and effective care, which fuels the demand for medical supplies.
The clinic segment is projected to witness the most rapid revenue growth throughout the forecast period. This growth is fueled by the proliferation of clinics in developing nations and an increasing emphasis on providing accessible and affordable healthcare. Clinics offer primary healthcare services and are equipped with standard medical tools, including stethoscopes, thermometers, and blood pressure monitors.
The home care settings category is also poised for significant expansion throughout the forecast period. This growth is attributed to the increasing preference for home-based healthcare services and the trend of aging in place.
Regional Market Analysis:
The North American region is poised to dominate the wearable artificial kidney market, primarily due to its high prevalence of chronic renal disease and favorable reimbursement policies. The National Kidney Foundation estimates that 37 million Americans currently suffer from chronic kidney disease, and this number is expected to rise in the coming years. This increasing prevalence in the region is anticipated to drive demand for wearable artificial kidney technologies. Additionally, the presence of several key competitors in the area, including CVS Health, and growing investments in the research and development of these devices are expected to support market expansion in North America.
The Asia Pacific region is forecasted to experience significant growth in the wearable artificial kidney market throughout the projection period. This can be attributed to the region's substantial population and the widespread occurrence of chronic kidney disease, particularly in countries like China and India. Expanding healthcare infrastructure and increased healthcare investments in the region are also expected to fuel the market for wearable artificial kidney devices.
In Europe, the market is expected to grow at a moderate rate during the forecast period. The rise in chronic renal disease prevalence and increased healthcare spending in the region are contributing factors. Additionally, government initiatives aimed at improving the healthcare system and raising awareness about renal diseases are expected to drive market expansion.
Competitive Landscape:
The global wearable artificial kidney market is projected to be moderately consolidated, with a few major players expected to hold a significant portion of the market share. Some of the prominent companies operating in the market include:
- Debiotech SA
- Baxter International Inc.
- Xcorporeal Inc.
- Synthetic Biologics Inc.
- Kidney Project
- AWAK Technologies
- Nephros Inc.
- American Renal Associates Holdings Inc.
- Fresenius Medical Care AG Co. KGaA
- Quanta Dialysis Technologies Ltd.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/7486
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Cerebral Infarction Treatment Market
Advanced Renal Cell Carcinoma Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
